compounded semaglutide crackdown news november 2025 π¨ FDA Moves to Shut Down Mass-Market GLP-1s The FDA is taking action to restrict widely marketed, nonβFDA-approved compounded GLP-1 products, citing concerns over safety, quality, and misleading claims. As demand FDA Intensifies Crackdown on GLP-1
Pay in 4 interest-free payments of $6.98 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 17 - Aug 22

























